To develop and validate a recalibrated prediction model (SCORE2-Diabetes) to estimate the 10-year risk of cardiovascular disease in individuals aged over 40 years with type 2 diabetes in four different European risk regions.
Autoren
- Isabell Bemfert
Publikation
- CARDIOVASC
Related Topics
You May Also Like
- Stroke
With polypills and co. against stroke and its consequences
- Post-COVID
Complaints from a neurological point of view
- Obstructive sleep apnea syndrome
Fitness to drive with OSAS
- Smoking cessation
On the way to better health – alternative nicotine products in view
- Age-related cognitive impairments
Ginkgo biloba extracts bring benefits
- Casuistry
SLE with kidney damage does not always have to be lupus nephritis
- Viral hepatitis
Hepatitis ABC(EN): Prophylaxis and treatment – an update
- Type 2 diabetes: reduction of microvascular and macrovascular risks